Ipratropium bromide and Estrace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ipratropium bromide (ipratropium bromide) and Estrace (estradiol). Common drug interactions include pneumonia among females.

The phase IV clinical study analyzes what interactions people have when they take Ipratropium bromide and Estrace. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

What is Estrace?

Estrace has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 16,703 Estrace users. Check the latest studies of Estrace.

On Jul, 21, 2026

60 people who take Ipratropium bromide and Estrace together, and have interactions are studied.

Ipratropium bromide and Estrace drug interactions.

What are the common drug interactions of Ipratropium Bromide and Estrace, by gender? *:

female:

Pneumonia
Sinusitis (inflammation of sinus)
Drug ineffective
Nasopharyngitis (inflammation of the nasopharynx)
Weight decreased
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)
Foot fracture
Influenza like illness
Infusion site erythema (reddening of the skin at infusion site)

male:

n/a

What are the common drug interactions of Ipratropium Bromide and Estrace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Respiratory failure (inadequate gas exchange by the respiratory system)
Rib fracture
Rigors (an episode of shaking or exaggerated shivering)
Sinusitis (inflammation of sinus)
Tremor (trembling or shaking movements in one or more parts of your body)
Anaphylactic reaction (serious allergic reaction)
Chest pain
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)
Epistaxis (bleed from the nose)

60+:

Pneumonia
Fatigue (feeling of tiredness)
Drug ineffective
Foot fracture
Infusion site swelling
Intestinal obstruction
Lung disorder (lung disease)
Neuropathy peripheral (surface nerve damage)
Application site erythema (redness of the skin at application site)
Application site pruritus (application site severe itching of the skin)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 15 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 13.33%
Pain: 7 people, 11.67%
Hypersensitivity: 7 people, 11.67%
Stress And Anxiety: 4 people, 6.67%
Constipation: 4 people, 6.67%
Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 6.67%
Primary Immunodeficiency Syndrome: 4 people, 6.67%
Vulvovaginal Pruritus (vulvovaginal severe itching): 3 people, 5.00%
Joint Pain: 3 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and Estrace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously